Get started
Author

Iván Noreña

Observed names: I. Noreña, Ivan Enrique Noreña, Ivan Norena, Ivan Noren᷉a, Ivan Noreña, Iván Noreña, MD., Noreña, Ivan, Noreña, Iván Enrique
Observed institutions: LMU Klinikum, Universidad Nacional de Colombia, German Center for Infection Research, Institute of Cardiology, Institut für Infektions- und Tropenmedizin, Ludwig-Maximilians-Universität München, Universidad del Rosario
ORCID: 0000-0001-5092-2589
Observed ORCID: 0000-0001-5092-2589
OpenAlex ID: A5016699323
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
2025 · Norbert Heinrich, Veronique de Jager, et al. · The Lancet Microbe · 30
PDF
Viral infections in the biologic therapy era
2018 · Ivan Noreña, Mario Fernández-Ruiz, et al. · Expert Review of Anti-infective Therapy · 24
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial
2025 · Norbert Heinrich, Norbert Heinrich, et al. · The Lancet Infectious Diseases · 20
PDF
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial
2025 · Lilian Tina Minja, Isabella van der Feltz, et al. · The Lancet Infectious Diseases · 18
PDF
Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers—ORCHESTRA Project
2023 · Ludovica Leomanni, Giulia Collatuzzo, et al. · Vaccines · 14
PDF
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
2023 · Emmanuel Musisi, Adam Wyness, et al. · The Lancet Microbe · 11
PDF
Endocarditis por Lactobacillus rhamnosus en un paciente con válvula aórtica bicúspide: ¿implicación potencial del consumo de probióticos?
2017 · Iván Noreña, Oscar Cabrera-Marante, et al. · Medicina Clínica · 10
First Case of Acquired Hemophilia B in a Patient with HIV Infection: Case Report and Literature Review
2019 · Laura Páramo, Leonardo Jose Enciso Olivera, et al. · Cureus · 8
PDF
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
2024 · Noemi Castelletti, Ivana Paunovic, et al. · Microbiology Spectrum · 7
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
2023 · Inge Kroidl, Simon Winter, et al. · Virology Journal · 7
PDF
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
2023 · Ronan Le Gleut, Michael Plank, et al. · BMC Infectious Diseases · 7
PDF
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
2023 · Christina Reinkemeyer, Yeganeh Khazaei, et al. · Viruses · 6
PDF
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
2025 · Simon E Koele, Krista Stoycheva, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
Mortalidad y desenlaces clínicos en pacientes críticamente enfermos con infecciones por bacterias productoras de carbapenemasas en un hospital de alta complejidad en Bogotá, Colombia
2020 · Fabio Andres Varón, Ana Maria Uribe, et al. · Infectio · 4
Endocarditis due to Lactobacillus rhamnosus in a patient with bicuspid aortic valve: Potential role for the consumption of probiotics?
2017 · Iván Noreña, Oscar Cabrera-Marante, et al. · Medicina Clínica (English Edition) · 4
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
2023 · Mohamed I. M. Ahmed, Michael Plank, et al. · Diagnostics · 2
PDF
Is there a real risk of bacterial infection in patients receiving targeted and biological therapies?
2022 · Ivan Noreña, Mario Fernández-Ruiz, et al. · Enfermedades infecciosas y microbiologia clinica (English ed ) · 2
Is there a real risk of bacterial infection in patients receiving targeted and biological therapies?
2020 · Ivan Noreña, Mario Fernández-Ruiz, et al. · Enfermedades Infecciosas y Microbiología Clínica · 2
Autoimmune hepatitis in human immunodeficiency virus infection: Case report and literature review
2017 · Ivan Noreña, Jairo A Morantes-Caballero, et al. · World Journal of Clinical Infectious Diseases · 2
Hepatic injury following colonoscopy
2013 · I. Noreña, A. Varón, et al. · Endoscopy · 2
Shaping opportunities for future clinical trials in tuberculosis
2025 · Ivan Noreña, Beno Mbeya, et al. · The Lancet Infectious Diseases · 1
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections
2024 · Christian Janke, Raquel Rubio-Acero, et al. · Viruses · 1
Proceedings from the CIHLMU Symposium 2020 on “eHealth: Trends and innovations”
2020 · Ivan Noreña, Nairuti Shah, et al. · BMC Proceedings · 1
PDF
A Patient With Human Herpesvirus 8-Positive Multicentric Castleman’s Disease Who Met Criteria for TAFRO Syndrome: Controversy in Practice?
2020 · Maria Cynthia Fuentes-Lacouture, Carmen C. Gomez, et al. · Journal of Medical Cases · 1
PDF
Refining research outcomes: Lessons from the setup of an endpoint review committee and radiological review in tuberculosis observational diagnostic studies
2026 · Leyla Larsson, Claire J. Calderwood, et al. · PLOS Global Public Health
Works count: 39
Citation count: 194
H-index: 8
I10-index: 7
Year
Topic
Type